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ALTHOUGH VASCULAR ENDOTHELIAL growth factor (VEGF) was originally identified by its ability to increase extravasation of plasma proteins (solute flux), how it accomplishes this remains unclear. It has been assumed that VEGF increases solute flux by stimulating microvascular endothelial cells to increase microvessel permeability (13) , although other parameters, such as microvessel surface area and driving forces, can increase solute flux. To address this problem, numerous studies have used a variety of approaches: measurements of in vivo transcapillary solute flux (31) , molecular localization of receptors for VEGF on endothelial cells in vivo (28) and in vitro (6) , in vitro measurements of intracellular Ca 2ϩ fluxes and growth assays in endothelial cells derived from various tissues (14) , and in vivo growth assays in a variety of vessels (12) . None of these studies has conclusively demonstrated that VEGF controls solute flux by acting directly on the capillary wall or on the cells forming the barrier for exchange. The difficulty in explaining the mechanism of solute flux increase, specifically, the transient increase induced by VEGF, arises from a lack of a wellcontrolled in vivo system that allows measurement of solute flux under known surface area and driving forces.
Three types of permeability coefficients can be directly measured across the microvascular wall: the solute permeability coefficient, the solute reflection coefficient, and the hydraulic conductivity (L p ) (15) . The first two coefficients describe the barrier properties of the microvessel wall to solutes, and the third parameter describes the barrier properties of the microvessel wall to water. Wu et al. (33) found in ex vivo coronary venules that VEGF increased apparent albumin permeability, which reached a maximum 5 min after stimulation and returned to control levels 5 min later in a nitric oxide-dependent manner. Exposure to 1 nM VEGF rapidly and transiently increased L p within 30 s (to 7.8 times baseline values) and returned to control within 2 min (8). After longer times (i.e., 24 h after 10 min of perfusion), VEGF increased L p to 6.8 times baseline without affecting the reflection coefficient to albumin (7) . Although there are several reports of increased L p in response to VEGF in intact microvessels (7-11, 20, 26, 27) , there are no data showing the increase and the history of the increase in permeability to various-sized solutes in response to VEGF. The first aim of the present study is to show that VEGF acutely increases permeability by measuring the solute flux for various-sized solutes [small (sodium fluorescein, mol wt 376, Stokes radius 0.45 nm), intermediate (␣-lactalbumin, mol wt 14,176, Stokes radius 2.01 nm), and large (BSA, mol wt 67,000, Stokes radius 3.5 nm)] under conditions of known surface area and driving forces. Sodium fluorescein can easily penetrate all the structural barriers in the interendothelial cleft. ␣-Lactalbumin has difficulty traveling through the surface glycocalyx. BSA is rarely transferred across the microvessel wall under normal conditions; its diameter is the cutoff size for the spacing between adjacent fibers in the surface glycocalyx (19, 32) . In conjunction with a model for the interendothelial cleft (19) , we use the distinct transport characteristics of these probe molecules and additional information from previous electron microscopy studies and the measurement of L p (8) to predict changes in structural components of the interendothelial cleft under the influence of VEGF.
The cleft between adjacent endothelial cells (interendothelial cleft) is widely believed to be the principal pathway for water and hydrophilic solute transport through the microvessel wall under normal physiological conditions (23) . The interendothelial cleft is also suggested to be the pathway for transport of highmolecular-weight plasma proteins, leukocytes, and tumor cells across microvessel walls in disease. Direct and indirect evidence (19, 32) indicates that there are tight junction strands with discontinuous leakages and fiber matrix components (glycocalyx layer) at the endothelial surface and within the cleft (Fig. 1) . These structural components of the microvessel wall form the barrier between the bloodstream and body tissues, which maintains the normal microvessel permeability to water and solutes.
The structural mechanisms that have been studied to increase microvessel permeability by VEGF, inflammatory mediators, and physical stimuli involve the formation of gaps between adjacent endothelial cells in venular microvessels (22) , vesiculovacuolar organelle pathways (16) , transcellular pores (16, 25) , and fenestra (16, 29) . However, there may be changes in the thickness and organization of the endothelial cell glycocalyx and more subtle changes in junction ultrastructure that do not lead to formation of the abovementioned pathways, especially in the case of an acute increase.
Microvessel hyperpermeability is the critical step for the abnormal transport of molecules and cells across the blood vessel and, thus, the crucial step for tumor growth and metastasis. Understanding the mechanisms of microvessel hyperpermeability from various approaches is important in combating these malignant diseases. The second aim of our study is to investigate the ultrastructural mechanisms of acute microvascular hyperpermeability induced by VEGF in intact microvessels by combining a theoretical model for the interendothelial cleft (19) and experimental data for microvessel permeability to water and various-sized solutes in intact microvessels. Here we test the hypothesis that VEGF induces acute (0-5 min) increases in microvessel permeability by destroying the integrity of the structural components in the cleft between endothelial cells forming the microvessel wall.
Solute permeability was measured by quantitative fluorescence microscope photometry (3, 17, 21) . All experiments were performed on individually perfused venular microvessels in frog mesentery. Each microvessel was perfused via two micropipettes to enable us to switch rapidly from a clear (washout) perfusate to one containing the fluorescently labeled test solute. This method allowed us to repeat measurements of solute permeability under more than one chemical treatment on each microvessel. In addition, permeability was measured by perfusing segments of the microvessel with fluorescently labeled solutes under conditions in which the transmicrovessel differences in solute concentration and hydrostatic pressure were known (21) .
MATERIALS AND METHODS

General
All in vivo experiments were performed on male leopard frogs (Rana pipiens, 2.5-3 in. long; J. M. Hazen, Alburg, VT). The methods used to prepare the frog mesentery, perfusate solutions, and micropipettes for microperfusion experiments have been described in detail elsewhere (3, 17, 21) . A brief outline of the methods is given with emphasis on the special features of the present experiments. The protocol (R714- Fig. 1 . A: 3-dimensional sketch of junction-orifice-matrix entrance layer model for interendothelial cleft (17) . Junction strand with periodic openings lies parallel to luminal front. There are 2 types of pores in junction strand. Large breaks, 2d ϫ 2B ϭ 150 ϫ 20 nm; small continuous slit, 2bsϷ 1.5 nm. B: plane view of model. L, total depth of cleft (ϳ400 nm); L1 and L3, depths between junctional strand and luminal and abluminal fronts, respectively; Lf, thickness of fiber matrix at cleft entrance; 2D, distance between 2 adjacent breaks in junctional strand; d, one-half width of large junctional breaks. Depth of pores in junction strand is ϳ10 nm. At entrance of cleft on luminal side, surface glycocalyx structures are represented by a periodic square array of cylindrical fibers. a, Radius of these fibers; ⌬, gap spacing between fibers.
1198-144) for the experiments was approved by IACUC of University of Nevada, Las Vegas.
The frog brain was destroyed by pithing, with the spinal cord left intact. The abdominal cavity was opened, and the mesentery was gently arranged on the surface of a polished quartz pillar (1 cm diameter; Heraeus-Amersil, Fairfield, NJ) to maintain circulation to the gut and mesentery of the animal. The upper mesentery was continuously superfused with frog Ringer solution at room temperature (ϳ23°C). Venular capillaries, generally 20-35 m diameter, were chosen for study. All vessels had brisk blood flow immediately before cannulation and had no marginating white blood cells. Each of the two arms of a Y-branched microvessel was cannulated with a beveled glass micropipette containing perfusion solution. This arrangement allowed alternate perfusion of the downstream vessel with a washout solution (containing no fluorescent solute) on one side and the test solution (containing the fluorescent solute) on the other side. Each pipette was connected to a water manometer that allowed perfusion at known pressures. For these experiments, the pressure was 5-10 cmH 2O, as determined by balancing the interface between fluorescent and nonfluorescent solution within the nonflowing arm of the Y-branched microvessel. In each vessel, permeability was determined for straight segments, 300-400 m long, Ն100 m downstream from the Y-branch junction point.
Frog Ringer solution was used for all dissections, perfusates, and superfusates. The solution composition was (in mM) 111 NaCl, 2.4 KCl, 1.0 MgSO4, 1.1 CaCl2, 0.195 NaHCO 3, 5.5 glucose, and 5.0 HEPES, with pH balanced to 7.4 by adjustment of the ratio of HEPES acid to base. In addition, the clear solution and the fluorescent dye solution contained BSA (catalog no. A4378, Sigma) at 10 mg/ml.
Fluorescent Test Solute Preparation
Sodium fluorescein. Sodium fluorescein (catalog no. F6377, Sigma; mol wt 376, Stokes-Einstein radius ϳ0.45 nm) was dissolved at 0.1 mg/ml in frog Ringer solution containing 10 mg/ml BSA. The solution was made fresh on the day of use to avoid binding to the serum albumin (4, 17) .
FITC-labeled ␣-lactalbumin and BSA. ␣-Lactalbumin (catalog no. L6010, Sigma; mol wt 14,176, Stokes-Einstein radius ϳ2 nm) and BSA (catalog no. A4378, Sigma; mol wt ϳ67,000, Stokes-Einstein radius ϳ3.5 nm) were labeled with FITC (catalog no. F7250, Sigma; mol wt 389.4), as described elsewhere (17, 21) . Briefly, protein (90 mg) was dissolved in 15 ml of borate buffer (0.05 M, pH ϳ9.3, 20°C) containing 0.4 M NaCl. The solution was placed in 18-mm-diameter dialysis tubing with a 3,500-mol-wt cutoff (Spectrum Medical Industries) and dialyzed for 12 h with constant stirring at 15°C against 50 ml of the borate buffer containing FITC (0.5 mM). The labeled protein then was dialyzed against 2 liters of glucose-free frog Ringer solution twice, each time for 12 h. Then the dialysis procedure was repeated twice with 2 liters of normal frog Ringer solution until there was no free dye. The influence of free dye on measured permeability to a labeled protein has been discussed previously (15) . FITClabeled ␣-lactalbumin and BSA were stored frozen and used within 2 wk of preparation. On the day of use, unlabeled BSA was added to aliquots of the labeled protein. The final FITC-␣-lactalbumin and FITC-BSA dye concentration was 2 mg/ml in frog Ringer solution. For this preparation, the fluorescence intensity of the free FITC dye was 1% of the solution and was checked using the photometer at the same instrument settings used in our experiments.
All dye solutions were kept chilled until just before use and were discarded at the end of the day.
Microscope and Photometer Preparation
A detailed description of the method used to measure permeability of fluorescently labeled solutes has been published previously (17, 21) . In the present experiment, we used a different but similar experimental setup. An inverted fluorescence microscope (Eclipse TE-300, Nikon) was used to observe the mesentery. A ϫ10 lens (NA 0.3, Nikon) gave a ϳ2-mm-diameter field of view. The tissue was observed with transmitted white light from a light pipe suspended above the preparation or with fluorescent light from a xenon lamp (300 W; Intracellular Imaging) with appropriate filter sets for fluorescein. The filter set (model XF23, Omega) that was used for sodium fluorescein, FITC-BSA, and FITC-␣-lactalbumin consisted of an excitation filter (model 485DF22), a dichroic mirror (model 505DRLP), and an emission filter (model 535DF35). The intensity of the xenon light source was controlled by an attenuator knob on the front panel of the lamp housing. The intensity of the light output can be adjusted from 0 to 100%. To reduce the tissue damage due to exposure to fluorescent light, the light intensity was kept as low as possible. Further protection was provided by using an experimental protocol in which the time of tissue exposure to the excitation light was kept as short as possible for the permeability measurement. Generally, exposure time for an individual measurement was 5-20 s. The larger the molecule, the longer was the exposure time. The fluorescence intensity (If) in the capillary lumen and surrounding tissue was measured by aligning the vessel segment within an adjustable measuring window consisting of a rectangular diaphragm in the light path. The maximum size of the window was 250 m wide and 650 m long. In our experiment, the dimensions of the measuring window were generally 100-200 m wide (ϳ5 times the microvessel diameter) and 300-500 m long. The measuring window was set Ն100 m from the base of the vessel to avoid solute contamination from the sidearm. I f measured by a photometer (model HC135-11, Hamamatsu) was recorded into a computer through an analog-to-digital board by using InCyt Pm1 Photometry software (Intracellular Imaging). Compared with previous strip chart recordings, this type of recording greatly improves the spatial and temporal resolution of the intensity vs. time curve, which is used to calculate solute permeability (P) as follows:
, where ⌬If 0 is the step increase in fluorescent light intensity as the test solute fills the microvessel lumen, (dI f /dt)0 is the initial rate of increase in fluorescence light intensity after solute fills the lumen and begins to accumulate in the tissue, and r is the microvessel radius (17, 21) .
Calibration Experiments
We used in vitro and in vivo calibration experiments to test the assumption in the calculation of solute permeability that If is a linear function of the number of solute molecules in the measuring field. The instrument settings used in the calibration experiments were the same as those used in the permeability measurements. For different-sized test solutes, we used different instrument settings by adjusting the intensity attenuator knob in the lamp housing to obtain enough fluorescent intensity for the measurement but to avoid tissue damage due to exposure to the fluorescent light.
In vitro calibrations were performed using two chambers of different depths: a 100-m-deep cell-counting chamber (hemocytometer; Hausser Scientific) and a ϳ170-m-deep chamber constructed of glass coverslips (4, 17) . Solutions of fluorescein were applied to fill the chamber by capillarity, and the intensity was measured. The chamber was cleaned before different concentrations of solutions were applied. These in vitro calibrations showed that the relation between the concentration and the fluorescence intensity was linear from 0.05 to 0.2 mg/ml for sodium fluorescein and from 0.3 to 6 mg/ml for FITC-␣-lactalbumin and BSA.
In the in vivo calibration experiment, a microvessel was cannulated and perfused as if for measurement of solute permeability. We recorded the step increase in I f 0 as the solute was perfused into the microvessel. Perfusion time was Ͻ5 s during each run to minimize accumulation in the surrounding tissue. The procedure was repeated on the same microvessel at each of four sodium fluorescein concentrations: 0.05, 0.1, 0.15, and 0.2 mg/ml. The step increase was plotted as a function of concentration. For FITC-␣-lactalbumin and FITC-BSA, different microvessels were used in in vivo calibrations. Four concentrations of FITC-␣-lactalbumin and FITC-BSA were used: 0.33, 0.67, 2, and 6 mg/ml. In vivo calibration results for the same concentration ranges used in the in vitro experiment are shown in Fig. 2 . Figure 2A shows the results of an experiment in which a microvessel was perfused with four concentrations of sodium fluorescein. Figure 2 , B and C, shows the results for FITC-␣-lactalbumin and FITC-BSA. The concentrations used in our experiments were 0.1 mg/ml for sodium fluorescein and 2 mg/ml for FITC-␣-lactalbumin and FITC-BSA.
Using in vivo experiments, we also determined whether the initial step of I f 0 was independent of the width of the measuring window when the capillary was aligned along the centerline of the window, provided the window was wider than and up to five times the diameter of the vessel. This experiment showed no contamination of our measuring window from dye leaked into the tissue during cannulation or diffused into the tissue from adjacent vessels. If there was contamination during the permeability measurement, the increase of If in the measuring window when the dye traveled out of the vessel and accumulated in the tissue would not be linear. When this occurred, the measurement was discarded.
Furthermore, we found in the in vitro photobleaching experiment that sodium fluorescein (0.1 mg/ml) and FITC-␣-lactalbumin and FITC-BSA (2 mg/ml) If values fell ϳ0.4, 0.3, and 0.7% of their original values, respectively, in 1 min. One minute was typically two to four times as long as the exposure time required for an individual solute permeability measurement. The much lower degree of photobleaching than in previous experiments (3, 17) was due to the reduction in excitation light intensity as a result of adjusting the attenuator knob of the light source. In addition, the shorter exposure time for the larger solute (BSA) in an individual permeability measurement was due to much higher sensitivity of the computer recording system (dI/If 0 ϳ1/10,000) than of the previously used strip chart recorder (ϳ1/100). In general, the present system is 100 times as sensitive as the chart recorder.
Experimental Protocol
To test the effect of 1 nM VEGF (human recombinant VEGF-165, Peprotech, Rocky Hill, NJ) on permeability of various-sized solutes, for each test solute, we made several control measurements when the washout pipette was filled with Ringer perfusate containing BSA (10 mg/ml) and the dye pipette was filled with the same perfusate to which the test solute was added. We then replaced washout and test pipettes with new pipettes that also contained VEGF (1 nM).
The concentration of VEGF was chosen to be consistent with that used in Lp measurements by Bates and Curry (8) . During the replacement of the pipettes, the pressures for washout and dye pipettes were dropped to Ͻ1 cmH 2O, so there was negligible flow at the tip during recannulation. Then pressure at the washout side was increased to 20-30 cmH 2O while pressure at the dye side was increased to 5-10 cmH2O to balance pressure at the washout side. These pressure settings were chosen for the perfusion of washout solution. After 10-15 s of perfusion with washout solution containing VEGF, pressure at the dye side was switched to 20-30 cmH 2O while pressure at the washout side was switched to 5-10 cmH2O for dye perfusion. Perfusion of dye solution containing 1 nM VEGF lasted 5-20 s, depending on solute size. From the initial step increase in fluorescence intensity of the test dye solution and its accumulation in the measuring window (see Calibration Experiments), we can calculate solute permeability. In this way, solute permeability was measured every 15-40 s, including dye (5-20 s) and washout perfusion (10-20 s) . During the washout perfusion, the test solute was washed out of the measuring window through the vessel, and we were able to make repeated permeability measurements of the same test solute at different times. The alternating perfusion of dye and washout solutions lasted ϳ5 min.
Analysis and Statistics
The nonparametric Wilcoxon signed-rank test was applied to the averaged permeability data to test statistical significance of the treatment over time. Mann-Whitney's U-test was applied to between-group data to test for permeability differences at specific times. Significance was assumed for probability levels Ͻ5%.
RESULTS
Control Measurement
To ensure that any changes in permeability after cannulation and perfusion with VEGF were not due to the effects of the recannulation procedure alone, we measured permeability at baseline and then immediately after cannulation and perfusion with 1% BSA (same solution as for baseline; Fig. 3 ). There was no change in permeability immediately after recannulation and perfusion with 1% BSA alone. For sodium fluorescein, the ratio (mean Ϯ SD) of the peak permeability (within 30 s) compared with baseline (calculated from each individual vessel) was 1.19 Ϯ 0.19 (n ϭ 5). The peak-to-baseline ratios were 1.11 Ϯ 0.42 (n ϭ 6) for ␣-lactalbumin and 0.93 Ϯ 0.58 (n ϭ 5) for BSA. These ratios indicate that the peak changes in permeability, on average, are 11-19% greater or 7% less than the baseline values. In comparison, if the maximum baseline values of permeability are expressed as a ratio of the baselines' means, then the change is 4-17% for these solutes. The variation in permeability measurement after recannulation and perfusion with 1% BSA was therefore no greater than the variation measured during baseline. Thus there was no significant transient increase in permeability by a second perfusion with a solution containing 1% BSA alone.
Microvessel Solute Permeability Response to VEGF
After baseline measurement in each vessel, we measured the acute response to 1 nM VEGF in 14 vessels for sodium fluorescein permeability, 17 vessels for ␣-lactalbumin permeability, and 15 vessels for BSA permeability. There was an immediate significant increase in apparent sodium fluorescein, ␣-lactalbumin, and BSA permeabilities (Fig. 3) . Because of the rapid nature of the response, not all the vessels had perme- ability measurements in all time bins (e.g., only 5, 9, and 4 vessels were measured within the first 15 s after perfusion with VEGF for sodium fluorescein, ␣-lactalbumin, and BSA permeabilities, respectively). Permeability (mean Ϯ SE) measured at the peak of the response was 9.6 Ϯ 2.0 ϫ 10 Ϫ5 cm/s for sodium fluorescein (n ϭ 14, range 2.7-28.3 ϫ 10 Ϫ5 cm/s) compared with a baseline permeability of 4.2 Ϯ 0.4 ϫ 10 Ϫ5 cm/s (n ϭ 14, range 1.6-7.8 ϫ 10 Ϫ5 cm/s, P Ͻ 0.015, Wilcoxon signed-rank test). This represents a mean peak increase in sodium fluorescein permeability of 2.3 Ϯ 0.4-fold compared with baseline in the same vessel (n ϭ 14, range 1-to 5.5-fold). For ␣-lactalbumin, the peak was 1.7 Ϯ 0.2 ϫ 10 Ϫ5 cm/s (n ϭ 17, range 0.68-3.3 ϫ 10 Ϫ5 cm/s) compared with a baseline permeability of 0.55 Ϯ 0.06 ϫ 10 Ϫ5 cm/s (n ϭ 17, range 0.15-0.9 ϫ 10 Ϫ5 cm/s, P Ͻ 0.01), representing a mean peak increase in ␣-lactalbumin permeability of 3.3 Ϯ 0.3-fold compared with baseline in the same vessel (n ϭ 17, range 1.8-to 5.6-fold). For BSA, the peak was 0.37 Ϯ 0.06 ϫ 10 Ϫ5 cm/s (n ϭ 15, range 0.11-0.74 ϫ 10 Ϫ5 cm/s) compared with a baseline permeability of 0.068 Ϯ 0.009 ϫ 10 Ϫ5 cm/s (n ϭ 15, range 0.03-0.13 ϫ 10
Ϫ5
cm/s, P Ͻ 0.01), representing a mean peak increase in BSA permeability of 6.2 Ϯ 1.2-fold compared with baseline in the same vessel (n ϭ 15, range 1.2-to 17.1-fold). These control values are slightly larger than previously measured data (3, 17, 21, 30). The most likely reason is that the temperature in our experiment, ϳ23°C, is slightly higher than that in previous experiments, 18-22°C. The increase was rapid, reaching a peak at 25.6 Ϯ 3.2 s for sodium fluorescein (n ϭ 14), 23.6 Ϯ 3.2 s for ␣-lactalbumin (n ϭ 17), and 29.9 Ϯ 3.2 s for BSA (n ϭ 15) after reperfusion of the vessel with the Ringer solution containing VEGF. The transient increase was substantially greater than baseline permeability in 64, 88, and 87% of vessels for sodium fluorescein, ␣-lactalbumin, and BSA, respectively (see DISCUSSION for definition of substantial increase). The increase became not significantly different from baseline ϳ95 s after reperfusion (P Ͼ 0.2 for all solutes). There was no change in vessel diameter during our measurements before and after VEGF perfusion for 5 min, as detected through eyepiece or measured I f 0 . Figure 4 summarizes the control and VEGF-induced peak values for apparent permeability of all three solutes. The corresponding values are shown in Table 1 and in the DISCUSSION for the values after the correction for free dye effect. The mean ratio of peak to control permeability of the large solute BSA (Stokes radius 3.5 nm) was 6.2, the highest among the three solutes. The ratio for the intermediate-sized solute ␣-lactalbumin (Stokes radius 2.01 nm) was 3.3, and that for the small solute sodium fluorescein (Stokes radius 0.45 nm) was 2.3. These values for the peak ratio, combined with the predictions from the previous model for the interendothelial cleft (19) , will help us elucidate the transient structural changes induced by VEGF. Figure 5 presents the corresponding true diffusive permeability after exclusion of the convective component as a result of filtration from the apparent permeability. The ratios of mean peak to control values in diffusive permeability are 4.9, 2.8, and 2.3 for BSA, ␣-lactalbumin (before correction for free dye influence), and sodium fluorescein, respectively.
Model Predictions
On the basis of experimental observations (1, 2, 5), Fu et al. (19) proposed a three-dimensional two-pathway model for the interendothelial cleft (Fig. 1) . Under normal physiological conditions when cleft width (2B) ϭ 20 nm, large break width (2d) ϭ 150 nm, small slit width (2b s ) ϳ 1.5 nm, spacing between adjacent large breaks (2D) ϭ 2,640 nm, cleft depth (L) ϭ 400 nm, L 1 ϭ L 3 ϭ 200 nm, fiber matrix thickness (L f ) ϭ 100 nm, fiber radius (a) ϭ 0.6 nm, and gap spacing between fibers (⌬) ϭ 7 nm, this model can successfully explain the data for permeability to water and solutes ranging from potassium to albumin in frog mesenteric microvessels.
To test the hypothesis that VEGF induces acute (0-5 min) increases in microvessel permeability by destroying the integrity of the structural components in the cleft between endothelial cells forming the microvessel wall, we changed the values for entrance L f , 2B, 2D, and 2d in our model. Figure 6A shows the effect of entrance L f . The glycocalyx layer on the endothelial surface is widely taken as the molecular sieve (23) to large solutes such as proteins. Removing or partially removing this layer would greatly increase the microvessel permeability to the large solute BSA and somewhat increase permeability to the intermediate-sized solute ␣-lactalbumin and the small solute sodium fluorescein and L p . Figure  6B shows the effect of increasing 2B. This would greatly increase L p and moderately increase permeability of various-sized solutes. Figure 6C shows the effect of increasing 2d in the junction strand. This would moderately increase L p and permeability to ␣-lactalbumin but have little effect on permeability to sodium fluorescein and no effect on permeability to BSA. Figure 6D shows the effect of decreasing 2D (or increasing the number of junction breaks). This has an effect that is similar to the effect of increasing the size of the breaks (Fig. 6C) .
DISCUSSION
Evaluation of Methods: Free Dye Associated With FITC-Labeled ␣-Lactalbumin and Albumin
We chose FITC as the labeling fluorophore for ␣-lactalbumin and albumin to obtain high quantum yield (ratio of the number of fluorescence photons emitted to the number of photons absorbed) with low light excitation. Because FITC (mol wt 389.4) diffuses through microvessel walls much faster than ␣-lactalbumin (mol wt 14,176) and albumin (BSA, mol wt 67,000), a small amount of the free FITC would cause a large overestimation of the permeability to ␣-lactalbumin and albumin molecules. We therefore measured the amount of free dye in our labeled ␣-lactalbumin and albumin solutions. After being ultrafiltered by a clinical centrifuge (1,750 rpm, 444 g) through a Centricon filter (Millipore, 3,000 mol wt cutoff) from the 2 mg/ml FITC-␣-lactalbumin or FITC-BSA solutions used in our experiments, the filtrate was checked for fluorescence intensity due to free FITC (I ff ). The method for measuring I ff is the same as that described in the in vitro calibration, and the instrument settings are the same as those used for the solute permeability measurements. The ratio of free dye to original solutions is ϳ1% for 2 mg/ml FITC-␣-lactalbumin and FITC-BSA solutions. If we use measured sodium fluorescein permeability (4.2 ϫ 10 Ϫ5 and 9.6 ϫ 10 Ϫ5 cm/s for control and peak VEGF effect, respectively) for FITC permeability of microvessels, because the molecular weight of FITC (389.4) is very close to that of sodium fluorescein (376), provided the permeability is determined by solute size, we can estimate the influence of free dye on ␣-lactalbumin and BSA permeability. With the use of the same method used in the appendix of Fu et al. (17) , F) ]P free dye (where P measure is the measured permeability for ␣-lactalbumin or BSA, P free dye is FITC permeability, F ϭ 1% is the intensity ratio of free dye filtrate to original FITC-␣-lactalbumin or FITC-BSA solutions, and P correct is the corrected permeability for ␣-lactalbumin or BSA), we estimated that free FITC dye would lead to an overestimation of ␣-lactalbumin permeability by 7% for control and 5% for VEGF measurements. However, the free dye would lead to an overestimation for BSA permeability by 62% for control and 24% for VEGF Values are means Ϯ SE; n, number of vessels. VEGF, vascular endothelial growth factor. measurements. After correction for free dye influence, ␣-lactalbumin permeability would be 0.51 ϫ 10 Ϫ5 cm/s and BSA permeability would be 0.026 ϫ 10 Ϫ5 cm/s under control and peak ␣-lactalbumin permeability would be 1.6 ϫ 10 Ϫ5 cm/s and peak BSA permeability would be 0.28 ϫ 10 Ϫ5 cm/s under VEGF treatment.
Solvent Drag Contribution to ␣-Lactalbumin and BSA Permeability
During permeability measurements, hydrostatic pressures in the microvessels were maintained at low levels (5-10 cmH 2 O). However, because solute flux can couple to water flow (solvent drag), the permeability coefficient measured in our experiments (apparent permeability) tends to overestimate the true diffusive permeability of intermediate-sized and large molecules. The relation between apparent permeability (P) and diffusive permeability (P d ) (15, 17) is as follows
where L p is hydraulic conductivity of the microvessel, is the reflection coefficient of microvessel to the solute, and Pe is the Peclet number, which is
where ⌬p eff is the effective filtration pressure across the microvessel wall, which can be expressed as
where ⌬p and ⌬ are the hydrostatic and osmotic pressure drops across the microvessel wall, respectively, and FITC-solute can be FITC-␣-lactalbumin or FITC-BSA.
In our experiments, ⌬p is 5-10 cmH 2 O, the reflection coefficient for albumin or FITC-albumin is 0.84 (7), the reflection coefficient for FITC-␣-lactalbumin is 0.35 (17, 21) , the osmotic pressure drop is 3.6 cmH 2 O for 10 mg/ml BSA, the osmotic pressure drop is 0.72 cmH 2 O for 2 mg/ml FITC-BSA, and the osmotic pressure drop (8) . Table 2 shows the effect of solvent drag on ␣-lactalbumin and BSA permeability. Under control, the solvent drag contributes 2% to ␣-lactalbumin permeability and 3% to BSA permeability when ⌬p eff is 1 cmH 2 O and 10% to ␣-lactalbumin permeability and 19% to BSA permeability when ⌬p eff is 6 cmH 2 O. Under VEGF treatment, the solvent drag contributes 5% to ␣-lactalbumin and BSA permeability when ⌬p eff is 1 cmH 2 O and 31% to ␣-lactalbumin permeability and 35% to BSA permeability when ⌬p eff is 6 cmH 2 O.
The much larger contribution of the solvent drag to apparent permeability of the proteins during VEGF treatment is due to the large increase in L p , which transiently jumps from a mean control of 2.6 ϫ 10
to a mean peak of 24.6 ϫ 10
, a ϳ10-fold increase. It may be also due to the decrease in the reflection coefficient of albumin (see below). Table 3 shows the results after the correction for effects of solvent drag and free dye. The control ␣-lactalbumin permeability would be 0. The calculations for the solvent drag effect shown above were made with the assumption that the reflection coefficient for BSA (0.84) is not changed during acute VEGF treatment. This assumption is based on the observation by Bates (7) that, after 24 h of exposure to VEGF, there was no change in albumin reflection coefficient. We now assume another limiting situation for a significant change in the reflection coefficient to albumin, which decreases from a control of 0.84 to 0.5. Under this assumption, the contribution of the solvent drag to apparent permeability is shown in Tables 2 and  3 . Because of the change in the reflection coefficient to albumin, ⌬p eff ranges from 3 to 8 cmH 2 O when the perfusion pressure (⌬p) is 5-10 cmH 2 O. For the case of reduced reflection coefficient to albumin, the contribution from the solvent drag term L p (1 Ϫ )⌬p eff in Eq. 1 would be 0.48 ϫ 10 Ϫ5 and 0.369 ϫ 10 Ϫ5 cm/s for ␣-lactalbumin and BSA permeability, respectively, when ⌬p eff is 3 cmH 2 O, and 1.3 ϫ 10 Ϫ5 and 0.98 ϫ 10
Ϫ5
cm/s for ␣-lactalbumin and BSA permeability, respectively, when ⌬p eff is 8 cmH 2 O. These high values for the solvent drag contribution to BSA permeability are close to or much greater than the measured apparent permeability (0.37 ϫ 10 Ϫ5 cm/s) without the correction for the free dye contribution. This may induce negative values for diffusive permeability when ⌬p eff is 8 cmH 2 O and when the apparent BSA permeability is used with the free dye correction (0.28 ϫ 10 Ϫ5 cm/s). The possible explanations are as follows: 1) the peak values for the apparent BSA permeability are not really the peak, as for L p , but an averaged value over a period, because of the limitation in the technique for the measurement of solute permeability (the real peak value should be higher); and 2) the reflection coefficient of albumin Values (without correction for free dye effect) are calculated from Eq. 1. ⌬peff, Effective filtration pressure across microvessel wall; Lp, hydraulic conductivity; Pe, Peclet number, P, apparent solute permeability (measured value); Pd, diffusive solute permeability. * Albumin reflection coefficient ϭ 0.84; †albumin reflection coefficient ϭ 0.5.
should not be reduced significantly under acute VEGF treatment. These calculations show that a reliable estimate of diffusive permeability for BSA may not be possible when the solvent drag accounts for most of the albumin flux.
Heterogeneity of Response to VEGF
The same criteria used by Bates and Curry (8) were chosen to determine whether a vessel was considered to have a significant response to perfusion with solutions containing VEGF. The rationale for the selection of the criteria was as follows. For example, the maximum increase (mean Ϯ SD) in sodium fluorescein permeability in the control vessels during a second consecutive perfusion with 1% BSA was 1.19 Ϯ 0.19 times the mean sodium fluorescein permeability during the original perfusion. An increase in sodium fluorescein permeability of Ͼ2 SDs greater than the mean increase [(2 ϫ 0.19) ϩ 1.19 ϭ 1.57-fold] was therefore accepted as a significant increase in sodium fluorescein permeability. Nine of 14 (64%) vessels increased their permeability to sodium fluorescein by Ͼ1.57-fold and were classified as responders. By the same criteria, 88 and 87% of vessels substantially responded to VEGF in ␣-lactalbumin and BSA permeability, respectively.
Not all vessels responded to VEGF in solute permeability according to this classification. This is consistent with the observation in L p experiments by Bates and Curry (8) . In their study, only 70% of microvessels responded to perfusion with solutions containing VEGF. This indicated a considerable degree of heterogeneity in the ability of the vessels to respond, although we always chose postcapillary venules for experiments.
Structural Mechanisms of VEGF Effect on Microvessel Permeability
We have compared our measured permeability data with the model predictions when the cleft width is increased (Fig. 7) . As shown in Fig. 7 , except for measured BSA permeability, all measured peak permeabil- Values are calculated from Eq. 1. Pc, apparent solute permeability after correction for free dye effect; see Table 2 footnote for other abbreviations. * Albumin reflection coefficient ϭ 0.84; † albumin reflection coefficient ϭ 0.5. ity data almost overlap the corresponding model predictions. This suggests that the acute increase in microvessel permeability induced by VEGF might be caused by a 2.5-fold transient increase in the width of the interendothelial cleft (Fig. 1) . Figure 6 , C and D, shows that the increase in the junctional break size or number of breaks would not change BSA permeability. However, Fig. 6A shows that removing the surface glycocalyx would induce a large increase in BSA permeability but minor increases in permeability to the other solutes. Therefore, the higher value in measured BSA permeability than the prediction in Fig. 7 would be explained by a partial removal or degradation (ϳ50%) of the surface fiber matrix (glycocalyx). The modeling conclusions apply only in the absence of significant solvent drag due to the possible unreliability in the estimation of diffusive permeability to BSA when the solvent drag accounts for most of the albumin flux.
Bates et al. (10) summarized that, under various conditions and in different types of blood vessels, VEGF can stimulate formation of a variety of pathways through the endothelial cell, including gaps between adjacent endothelial cells in venular microvessels (22) , vesiculovacuolar organelle formation (16), transcellular pores (16, 25) , and fenestra (16, 29) . Michel and Neal (25) used electron microscopy to study the mechanism of increased permeability by VEGF. They found that, after ϳ10 min of perfusion with 1 nM VEGF in microvessels, the pores observed by electron microscopy were almost transcellular, instead of intercellular. Some of these structures may be more consistent with a transport mechanism dominated by the solvent drag. Although these are alternative possibilities of structural mechanisms for VEGF-induced microvessel hyperpermeability, the method of combining the experimental results and the theoretical model predictions provides a useful tool for elucidating the transient structural changes induced by VEGF during the period from a few seconds to a few minutes.
In summary, the present study shows that frog mesenteric microvessels respond acutely to 1 nM VEGF by a rapid and transient increase in permeability to sodium fluorescein, ␣-lactalbumin, and BSA. Combination of these data and previous data for L p (8) with a model for the interendothelial cleft (19) suggests that the possible structural changes by VEGF would be a ϳ2.5-fold increase in the opening width of the interendothelial cleft and a partial degradation of the surface glycocalyx. Similar to L p in previous experiments (8) , there is considerable heterogeneity in the initial response, with significant increases in permeability to sodium fluorescein, ␣-lactalbumin, and BSA in only 64, 87, and 88% of the vessels, respectively. This work is supported by National Cancer Institute Grant R15 CA-86847-01, a National Science Foundation Career Award, and the University of Nevada, Las Vegas, Applied Research Initiative.
